Search

Search Results

• Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia

  Anastasiya Aleksandrovna Semenova, A.S. Luchinin, A.S. Subbotin, G.S. Tumyan, A.V. Arakelyan, A.I. Cherencova, S.S. Kamyshanov

  388-394

  01.10.2025

• Efficacy and Safety of Ruxolitinib in Primary Myelofibrosis Patients with Abdominal Thrombotic Complications: A Case Series

  Yu.P. Martinova, E.V. Borovitskaya, S.S. Lebedeva, E.R. Efimova, O.E. Filippova, K.M. Chernysh, A.P. Smaglyuk, L.I. Napso, N.V. Novospasskaya, L.V. Kucheryavykh, Tamara Vangelevna Chitanava

  250-256

  01.07.2025

• Myeloid Sarcoma with Skin and Spinal Lesions and KRAS Gene Mutation, Complicated by Secondary Hemophagocytic Syndrome: A Case Report and Literature Review

  Tatyana Nikolaevna Tolstykh, O.L. Kochneva, E.N. Misyurina, E.A. Baryakh, M.A. Mingalimov, K.V. Yatskov, S.A. Kardovskaya, D.D. Ivanova, T.S. Chudnova, D.V. Lebedev, A.N. Titova, E.I. Zhelnova

  242-249

  01.07.2025

• The Role of Somatic Mutations in Various Genes and the Issue of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A Literature Review

  Elena Andreevna Kuzmina, E.Yu. Chelysheva, B.V. Biderman, A.G. Turkina

  10-20

  01.01.2025

• Supportive Therapy in Multiple Myeloma: Practical Recommendations

  Maksim Valerevich Solovev, M.V. Soloveva, L.P. Mendeleeva

  426-448

  28.09.2023

• Classic and Activating Chimeric Antigen Receptors PD-1 as an Element of Multi-Target Approach to the Treatment of Hematological and Solid Neoplasms

  Kseniya Aleksandrovna Levchuk, A.A. Goldaev, E.A. Stolyarova, P.A. Mateikovich, A.Kh. Valiullina, E.R. Bulatov, A.V. Petukhov, A.A. Daks, N.A. Barlev, E.V. Baidyuk, Ya.G. Toropova

  268-279

  09.06.2023

• Quality of Life Changes in Patients with Chronic Immune Thrombocytopenia in the Process of Romiplostim Therapy, its Efficacy and Safety in the Real-World Setting: Results of a Multi-Center Observational Study

  T.I. Ionova, O.Yu. Vinogradova, T.V. Shelekhova, D.G. Sherstnev, A.V. Proidakov, E.V. Lyyurova, M.M. Pankrashkina, L.A. Mukha, E.E. Markova, N.V. Novitskaya, T.I. Pospelova, T.N. Babaeva, N.B. Bulieva, G.B. Kuchma, E.A. Andreevskaya, E.E. Zinina, M.V. Frolova, K.B. Trizna, I.L. Shestopalova, T.V. Shneider, S.A. Volkova, S.G. Zakharov, I.I. Mulina, I.E. Solov’eva, A.A. Myasnikov, A.A. Kuchin, L.B. Khvorostenko, N.M. Porfirieva, Tatyana Pavlovna Nikitina, V.V. Ptushkin, S.V. Gritsaev

  154-165

  03.03.2023

• Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

  I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva

  166-173

  03.03.2023

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Combination of Ibrutinib and Venetoclax in the Therapy of Chronic Lymphocytic Leukemia: A Review of the Latest Data from Clinical Studies

  A.A. Petrenko, Mariya Igorevna Kislova, E.A. Dmitrieva, E.A. Nikitin, V.V. Ptushkin

  37-45

  01.01.2023

• Efficacy and Safety of Midostaurin Combined with Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation

  Sergei Nikolaevich Bondarenko, A.G. Smirnova, B.I. Ayubova, E.V. Karyagina, O.S. Uspenskaya, Yu.S. Neredko, A.P. Kochergina, I.A. Samorodova, E.A. Pashneva, Yu.S. Chernykh, Yu.A. Dunaev, N.B. Esef’eva, R.K. Il’yasov, T.I. Brazhkina, I.A. Novokreshchenova, Z.K. Simavonyan, E.I. Kuzub, V.I. Bakhtina, T.I. Olkhovich, M.V. Burundukova, E.V. Babenko, Yu.D. Oleinikova, I.M. Barkhatov, T.L. Gindina, I.S. Moiseev, A.D. Kulagin

  167-175

  01.04.2022

• Pharmacoeconomic Analysis of Gilteritinib in the Therapy of Adult Patients with Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Mutation

  A.S. Kolbin, Yuliya Mikhailovna Gomon, Yu.E. Balykina, M.A. Proskurin

  85-96

  01.01.2022

• Immune Reconstitution Inflammatory Syndrome and Hodgkin’s Lymphoma

  Aleksandr Vasilevich Pivnik, A.M. Vukovich, A.A. Petrenko

  378-385

  01.07.2021

• Current Issues of Targeted Therapy of Polycythemia Vera

  Anait Levonovna Melikyan, I.N. Subortseva

  355-360

  01.07.2021

• Treatment of Mastocytosis: A Literature Review

  Karina Maksimovna Chernavina, A.S. Orlova, E.A. Nikitin

  361-369

  01.07.2021

• CAR-Т Cells for the Treatment of Chronic Lymphocytic Leukemia: Literature Review

  Irina Vladimirovna Gribkova, A.A. Zav’yalov

  225-230

  01.04.2021

• National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

  Anait Levonovna Melikyan, A.M. Kovrigina, I.N. Subortseva, V.A Shuvaev, E.V. Morozova, E.G. Lomaia, B.V. Afanasyev, T.A. Ageeva, V.V. Baikov, O.Yu. Vinogradova, S.V. Gritsaev, A.Yu. Zaritskey, T.I. Ionova, K.D. Kaplanov, I.S. Martynkevich, T.A. Mitina, E.S. Polushkina, T.I. Pospelova, M.A. Sokolova, A.B. Sudarikov, A.G. Turkina, Yu.V. Shatokhin, R.G. Shmakov, V.G. Savchenko

  262-298

  01.04.2021

• Current View on Diagnosis and Treatment of Classical Ph-Negative Myeloproliferative Neoplasms

  Anait Levonovna Melikyan, I.N. Subortseva, V.A. Shuvaev, E.G. Lomaia, E.V. Morozova, L.A. Kuzmina, O.Yu. Vinogradova

  129-137

  01.01.2021

• Gynecological Myeloid Sarcoma: Literature Review and a Case Report

  Aleksina Alekseevna Shatilova, L.L. Girshova, D.V. Zaitsev, I.G. Budaeva, Yu.V. Mirolyubova, D.V. Ryzhkova, R.V. Grozov, K.V. Bogdanov, T.S. Nikulina, D.V. Motorin, D.B. Zammoeva, S.V. Efremova, V.V. Ivanov, A.V. Petukhov, Yu.A. Alekseeva, A.Yu. Zaritskey

  31-44

  01.01.2021

• Chronic Lymphocytic Leukemia in Blood Relatives: Two Case Reports of Male Siblings

  Nadezhda Viktorovna Kurkina, E.A. Repina

  69-72

  01.01.2021

• Early Response and Long-Term Outcomes of Ruxolitinib Therapy in Myelofibrosis: Multicenter Retrospective Study in 10 Centers of the Russian Federation

  E.G. Lomaia, Nadiya Tamazovna Siordiya, O.M. Senderova, O.E. Ochirova, E.B. Zhalsanova, A.Yu. Furtovskaya, G.P. Dimov, M. G. Pozina, O.Yu. Li, K.B. Trizna, M.A. Mikhalev, E.V. Sokurova, A.A. Otmorskaya, A.S. Khazieva, V.V. Ust’yantseva, Yu.D. Rogovaya, A.Yu. Zaritskey

  335-345

  01.07.2020

• Breakthrough Hemolysis as a Challenging Issue in Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria (Resolution of Expert Panel)

  354-356

  01.07.2020

• Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

  Elena Romanovna Shilova, T.V. Glazanova, Zh.V. Chubukina, O.E. Rozanova, M.N. Zenina, A.V. Seltser, V.I. Rugal, V.A. Balashova, V.A. Kobilyanskaya, I.I. Krobinets, V.Yu. Udal’eva, I.I. Zotova, L.V. Stelmashenko, N.A. Romanenko, T.B. Zamotina, I.V. Khorsheva, S.V. Voloshin

  319-328

  01.07.2019

• WT1 Gene Overexpression in Differential Diagnosis of Ph-negative Myeloproliferative Disorders

  E.G. Lomaia, Nadiya Tamazovna Siordiya, E.G. Lisina, O.M. Senderova, A.A. Silyutina, A.Yu. Zaritskey

  297-302

  01.07.2019

• Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

  Vladimir Ivanovich Vorob’ev, V.A. Zherebtsova, E.I. Dubrovin, L.A. Bychenkova, Yu.B. Kochkareva, L.A. Mukha, V.L. Ivanova, N.K. Khuazheva, V.V. Ptushkin

  165-172

  01.04.2019

• Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

  Sergei Nikolaevich Bondarenko, E.N. Parovichnikova, A.A. Maschan, O.Yu. Baranova, T.V. Shelekhova, V.A. Doronin, V.Ya. Mel’nichenko, K.D. Kaplanov, O.S. Uspenskaya, A.N. Sokolov, N.V. Myakova, I.S. Moiseev, I.V. Markova, E.I. Darskaya, A.G. Smirnova, T.A. Bykova, B.I. Ayubova, I.A. Samorodova, E.V. Babenko, I.M. Barkhatov, T.L. Gindina, A.D. Kulagin, B.V. Afanas’ev

  145-153

  01.04.2019

• Resolution of Expert Panel for the Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria

  240-242

  01.04.2019

• Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)

  Ekaterina Vadimovna Motyko, O.V. Blau, L.B. Polushkina, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, Yu.S. Ruzhenkova, E.V. Kleina, N.B. Pavlenko, A.M. Radzhabova, E.V. Karyagina, O.S. Uspenskaya, S.V. Voloshin, A.V. Chechetkin, I.S. Martynkevich

  211-219

  01.04.2019

• Current Issues in Carcinogenesis

  Irina Viktorovna Vysotskaya, V.P. Letyagin, M.A. Shabanov, V.Yu. Kirsanov, E.A. Kim, N.V. Levkina

  101-106

  01.01.2019

• PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma

  Elena Andreevna Demina

  213-219

  01.07.2018

• Tyrosine Kinase Inhibitor Resistance in Patients with Chronic Myeloid Leukemia: A 10-Year Study of BCR-ABL Gene Mutation Profile in Russia (2006–2016)

  Vera Vyacheslavovna Tikhonova, M.A. Isakov, V.A. Misyurin, Yu.P. Finashutina, L.A. Kesaeva, N.A. Lyzhko, I.N. Soldatova, N.N. Kasatkina, E.N. Misyurina, A.V. Misyurin

  227-233

  01.07.2018

• The Use of Brentuximab Vedotin in Relapsed/Refractory Hodgkin’s Lymphoma in the Kransnodar Region

  Ol’ga Dmitrievna Serdyuk, D.A. Yaskul’skii

  50-53

  01.01.2018

• Targeted Therapy of Myelofibrosis

  Ol’ga Yur’evna Vinogradova, V.A. Shuvaev, I.S. Martynkevich, M.M. Pankrashkina, M.S. Fominykh, E.V. Efremova, K.Yu. Krutikova, L.B. Polushkina, N.N. Sharkunov, S.V. Voloshin, A.V. Chechetkin

  471-478

  01.10.2017

• Application of Modern Genome Technologies in Treatment of Lymphomas

  Marina Vyacheslavovna Nemtsova, M.V. Maiorova

  265-270

  01.07.2016

• Polycythemia Vera: Literature Review and Own Data

  Irina Nikolaevna Subortseva, T.I. Kolosheinova, E.I. Pustovaya, E.K. Egorova, A.M. Kovrigina, Yu.V. Pliskunova, T.V. Makarik, A.O. Abdullaev, A.L. Melikyan

  397-412

  01.10.2015

• Multiple Myeloma: 7-Year Experience of Applying Targeted Therapy in Novosibirsk and Its Results

  T.I. Pospelova, Nataliya Valer’evna Skvortsova, I.N. Nechunaeva

  267-273

  01.07.2015

• Cardiovascular complications of chronic myeloid leukemia treated with tyrosine kinase inhibitors

  G.E. Gendlin, L.M. Makeeva, E.I. Emelina, K.V. Shuikova, G.I. Storozhakov

  78-84

  01.01.2013